Pfizer: to present its research at ESMO

(CercleFinance.com) - Pfizer will present research across its oncology portfolio at the European Society for Medical Oncology (ESMO) 2024 Congress, to be held September 13-17 in Barcelona.


Data from over 50 research abstracts including more than 10 oral and mini-oral presentations, will be presented in the company's core tumor fields and scientific modalities, as well as a potential treatment for a cancer-related disease.

' At this year's ESMO, we look forward to demonstrating our progress toward delivering next-generation biologics and new combinations that have the potential to become new standards of care for patients,' said Chris Boshoff, Pfizer's head of oncology and executive vice president.

' Our key data presentations highlight our scientific leadership in the development of targeted therapies, including small molecules and antibody-drug conjugates, in our major tumor areas, including breast, bladder and thoracic cancers. '

Copyright (c) 2024 CercleFinance.com. All rights reserved.